PubMed 38. Wang XQ, Sun P, O’Gorman M, Tai T, Paller AS: Epidermal growth factor receptor glycosylation is required
for ganglioside GM3 binding and GM3-mediated suppression [correction of suppression] of activation. Glycobiology 2001, 11: 515–522.CrossRefPubMed 39. Wang X, Zhang S, MacLennan GT, Eble JN, Lopez-Beltran A, Yang XJ, Pan CX, Zhou H, Montironi R, Cheng L: Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res 2007, 13: 953–957.CrossRefPubMed 40. Guo P, Wang QY, Guo HB, Shen ZH, Chen HL: N -Acetylglucosaminyl-transferase V modifies GPCR & G Protein inhibitor the signaling pathway of epidermal growth factor receptor. Cell Mol Life Sci 2004, 61: 1975–1804.CrossRef 41. Maines MD: Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling AG-881 purchase pathways. Antioxid Redox Signal 2007, 9: 2187–2195.CrossRefPubMed 42. Campbell M, Allen WE, Sawyer C, Vanhaesebroeck B, Trimble ER: Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling
pathways. Circ Res 2004, 95: 380–388.CrossRefPubMed 43. Martin MM, Buckenberger JA, Jiang J, Malana GE, Knoell DL, Feldman DS, Elton TS: TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol 2007, 293: L790-L799.CrossRefPubMed 44. Westwood JA, Smyth MJ, Teng MW, Moeller M, Trapani JA, Scott AM, Smyth FE, Cartwright GA, Power BE, learn more Hönemann D, Prince HM, Darcy
PK, Kershaw MH: Adoptive transfer of T cells modified with a humanized chimeric receptor Carnitine palmitoyltransferase II gene inhibits growth of Lewis-Y-expressing tumors in mice. Proc Natl Acad Sci USA 2005, 102: 19051–19056.CrossRefPubMed 45. Halloran MM, Carley WW, Polverini PJ, Haskell CJ, Phan S, Anderson BJ, Woods JM, Campbell PL, Volin MV, Bäcker AE, Koch AE: Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol 2000, 164: 4868–4877.PubMed 46. Kudryashow V, Glunz PW, Williams LJ, Hintermann S, Danishefsky SJ, Lloyd KO: Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis y conjugates in mice. Proc Natl Acad Sci USA 2001, 98: 3264–3269.CrossRef 47. Livingston PO, Ragupathi G: Cancer vaccines targeting carbohydrate antigens. Hum Vaccin 2006, 2: 137–143.PubMed Competing interests The authors declare that they have no competing interests. Authors’ contributions JL carried out most parts of the experiment; YH, LZ, FL, DL, JC and SZ participated in the experiment; BL participated in the design of the study; YQ performed the statistical analysis; IM participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.